Background: The quality of life (QoL) of patients with lung cancer (LC) may be affected by disease-related limitations such as patients’ functioning, the severity of symptoms, financial problems resulting along with the side effects of the treatment. The objective of this study was to translate LC-specific QoL questionnaire EORTC QLQ-LC29 into Nepalese language for Nepalese LC patients. Methods: In the process of translation, the European Organization for Research and Treatment of Cancer (EORTC) translations guidelines were followed. The translated questionnaire was pilot-tested in a sample of 15 patients with LC. Descriptive statistics were calculated with SPSS version 21.0. Results: All steps of the EORTC translation guideline were follow...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Abstract Background A questionnaire developed in one language must be translated and adapted when it...
Abstract Background The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 i...
Abstract Background The latest European Organisation for Research and Treatment of Cancer (EORTC) Qu...
Background: The European Organisation for Research and Treatment of Cancer quality of life (EORTC QL...
Aim: The aim is to translate and validate the European Organization for Research and Treatment for C...
The European Organization for Research and Treatment of Cancer (EORTC) QLQ-LC13 was the first module...
Aims: To present the first cross-culture validation of the European organization for research and t...
Aims: To present the first cross-culture validation of the European organization for research and t...
The purpose of this study was to validate the core EORTC quality of life questionnaire, the QLQ-C30 ...
BACKGROUND The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life...
BACKGROUND The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life...
Background The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Qu...
Aim This study was aimed to translate an updated European Organization for Research and Treatment of...
Abstract: Background The European Organisation for Research and Treatment of Cancer (EORTC) Quality ...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Abstract Background A questionnaire developed in one language must be translated and adapted when it...
Abstract Background The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 i...
Abstract Background The latest European Organisation for Research and Treatment of Cancer (EORTC) Qu...
Background: The European Organisation for Research and Treatment of Cancer quality of life (EORTC QL...
Aim: The aim is to translate and validate the European Organization for Research and Treatment for C...
The European Organization for Research and Treatment of Cancer (EORTC) QLQ-LC13 was the first module...
Aims: To present the first cross-culture validation of the European organization for research and t...
Aims: To present the first cross-culture validation of the European organization for research and t...
The purpose of this study was to validate the core EORTC quality of life questionnaire, the QLQ-C30 ...
BACKGROUND The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life...
BACKGROUND The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life...
Background The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Qu...
Aim This study was aimed to translate an updated European Organization for Research and Treatment of...
Abstract: Background The European Organisation for Research and Treatment of Cancer (EORTC) Quality ...
To access publisher's full text version of this article. Please click on the hyperlink in Additional...
Abstract Background A questionnaire developed in one language must be translated and adapted when it...
Abstract Background The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 i...